The extent of the acute phase response and the relation between acute phase proteins and cytokines in plasma was investigated in 50 patients with fulminant hepatic failure. On admission, C reactive protein was significantly higher in fulminant hepatic failure (median: 12-4 ig/ml, range: 0-2-112 jig/ml) than in 20 controls (median: 0.8 ,ug/ml, range: 0*3-2-9 jig/ml, p<0-001). Serial measurements showed that plasma C reactive protein increased daily after admission until day 5, the end of the study period.
ot1-Antitrypsin (AAT) (median: 69l1%, range: 27.5-124%) and fibrinogen (median: [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] g/l, range: 0-2-82 g/l) were significantly lower in fulminant hepatic failure on admission than in controls (AAT: median: 126%, range: 75-4-149%; fibrinogen: median 2-48 g/l, range: 1i82-3-39 g/l, p<0-001) and did not change subsequently. Both AAT and fibrinogen were maintained at significantly higher concentrations in survivors than in those who did not. Bacterial infection occurred in 23 patients during the course of fulminant hepatic failure, but did not influence the concentrations of these three proteins. Interleukin 6 was significantly higher in fulminant hepatic failure (median: 21*2 pg/ml, range: 0-871 pg/ml) than in controls (median: [2] [3] [4] pg/ml, range: 1i5-8-2 pg/ml, p<0001). There was a significant correlation between interleukin 6 and the C reactive protein concentrations in patients with viral hepatitis on admission and in all patients 48 (Table II) . Concentrations were significantly higher in patients with fulminant hepatic failure resulting from viral hepatitis and causes other than paracetamol overdose (Table II) . There were no significant differences in C reactive protein concentrations between survivors and non-survivors (Table  II) or between 23 patients with and 27 without bacterial infection. Plasma C reactive protein during the course of the illness was in general higher in non-survivors than in survivors from day 3 to day 5 (the end of the study period), although this did not reach statistical significance (Fig 1) . Patients who received a liver transplant are not included in any serial data. Plasma AAT on admission was significantly lower in fulminant hepatic failure than in controls (Table II) . Although plasma concentrations of AAT were significantly higher in survivors than in non-survivors, the concentrations even in survivors were significantly lower than in controls (Table II) . Plasma AAT was less reduced than another protease inhibitor AT-III, which is not an acute phase protein, and AT-Ill was also significantly lower in fulminant hepatic failure than in controls (Table  II) . There were no significant differences in plasma AAT between patients with and without bacterial infection, or between patients with fulminant hepatic failure resulting from paracetamol overdose and viral hepatitis and other causes (Table II) . The serial plasma concentrations of AAT did not change after admission. AAT remained at significantly (p<005) higher concentrations in survivors than in non-survivors over the five days of study, and was maintained at more than 70% of normal (Fig 2) . In contrast with AAT, plasma AT-III in the overall fulminant hepatic failure group continued to decrease from the admission value to 10-3% of normal.
Plasma fibrinogen on admission was also significantly lower in fulminant hepatic failure than in controls (Table II) . There were no significant differences between patients with and without bacterial infection, or between patients with fulminant hepatic failure resulting from paracetamol overdose and viral hepatitis and other causes or between survivors and non-survivors (Table II) . Serial plasma concentrations of fibrinogen did not change after admission. Survivors continued to have significantly higher fibrinogen concentrations than non-survivors from day 2 to day 5 and the values were maintained at more than 1-2 g/l.
CYTOKINE CONCENTRATIONS AND CORRELATIONS WITH ACUTE PHASE PROTEINS
On admission, plasma interleukin 6 was significantly higher in patients with fulminant hepatic failure than in controls (Table II) . Concentrations were significantly higher in patients who did not survive than in survivors (Table II) , and no patient survived with an interleukin 6 concentration of more than 300 pg/ml. The pattern of interleukin 6 concentrations in fulminant hepatic failure did not change after admission. Interleukin 6 in nonsurvivors continued to be at significantly higher values than in survivors (day 2 and day 3; p<0-001 and p<0 05) (Fig 3) . There was no significant difference in interleukin 6 survivors, between patients with and without
In the patients with fulminant hepatic bacterial infection or between patients with failure, AAT and fibrinogen were decreased on fulminant hepatic failure resulting from admission to 69 and 45% of normal values paracetamol overdose and viral hepatitis and respectively. The higher AAT and fibrinogen other causes (Table II) . Both patients whose concentrations found in the survivors suggests interleukin 1 concentrations were more than that the prognosis is poor for those patients 20 pg/ml (24-4 and 144 pg/ml) had fulminant who cannot maintain both AAT and fibrihepatic failure resulting from hepatitis B virus nogen during the course of fulminant hepatic infection.
failure, although there was some overlap The correlation between interleukin 6 and between the two groups. Whether the decrease C reactive protein on admission was significant in values of the two proteins is also because of in the patients with fulminant hepatic failure their increased consumption is not clear. resulting from viral hepatitis (r=0-883, n=8, There is evidence for the latter in that p = 0-004) but not in the paracetamol overdose increased values of elastase-AAT complexes patients (r= -0 105). There was a correlation are found in fulminant hepatic failure7 and in all patients between interleukin 6 on admis-thus AAT, which is the major inhibitor of sion and plasma C reactive protein 48 hours elastase released from activated neutrophils, is later (r= 0-4 10, n = 27, p = 0 034). consumed in this process. Similarly, disInterleukin 6 on admission correlated seminated intravascular coagulation, which inversely with AAT (r= -04 414, n = 38, consumes fibrinogen, occurs in patients with p = 0010) and with fibrinogen (r= -0 370, fulminant hepatic failure.27 28 In this study the n = 38, p = 0 022) concentrations 24 hours concentrations of AAT and fibrinogen were later. Interleukin 6 correlated significantly greater than those of ATIII (23%), which is with prothrombin time (r=0-291, n=47, also synthesised in the liver but is not an acute p = 0-048) on admission. Plasma interleukin 1 30 The persistence of interleukin 6 in fulminant hepatic failure could point to decreased clearance as an additional factor. The lack of correlation between plasma interleukin 6 and serum creatinine would support the liver as being the main site of clearance of interleukin 6, as previously reported.3' We found no evidence of increased plasma interleukin 1 in this study, although in an earlier study increased interleukin 1 and tumour necrosis factor production were found with fulminant hepatic failure mononuclear cells in vitro.19
In keeping with interleukin 6 being a stimulator of the acute phase response, a significant correlation between plasma interleukin 6 and C reactive protein has been described after surgery,32 33 
